Gisela Mir Arnau

Vall d'Hebron Institute of Oncology

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (8)

Izabela Todorovski

Københavns Universitet

DENMARK

View details

Mary-Anne Young

Head

Garvan Institute of Medical Research

AUSTRALIA

View details

Yeh Chen Lee

Conjoint Senior Lecturer

University of New South Wales

AUSTRALIA

View details

Wayne Phillips

Adjunct Professor

Monash Health

AUSTRALIA

View details

Joanna Groom

Laboratory Head

Walter and Eliza Hall Institute of Medical Research

AUSTRALIA

View details

Dale Garsed

University of Melbourne

AUSTRALIA

View details

Xavier Maldonado

Head of Department

Hospital Universitari Vall d'Hebron

SPAIN

View details

Mark Shackleton

Professor Director of Oncology

Alfred Health

AUSTRALIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gisela Mir Arnau

Research Interests

Explore related searches

Contact this professor

Articles (10)

Harnessing Senolytics and PARP Inhibition to Expand the Antitumor Activity of CDK4/6 Inhibitors in Prostate Cancer

Homologous recombination repair status in metastatic prostate cancer by next-generation sequencing and functional immunofluorescence

RNA kinetics influence the response to transcriptional perturbation in leukaemia cell lines

Circulating tumor extracellular vesicles to monitor metastatic prostate cancer genomics and transcriptomic evolution

TRACEBACK: Testing of Historical Tubo-Ovarian Cancer Patients for Hereditary Risk Genes as a Cancer Prevention Strategy in Family Members

TRACEBACK: Testing of Historical Tubo-Ovarian Cancer Patients for Hereditary Risk Genes as a Cancer Prevention Strategy in Family Members

Epigenetic modulators of B cell fate identified through coupled phenotype-transcriptome analysis

Tumor-Infiltrating Neutrophils after Neoadjuvant Therapy are Associated with Poor Prognosis in Esophageal Cancer.

Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML.

Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling

Collaborators (8)

Izabela Todorovski

Mary-Anne Young

Yeh Chen Lee

Wayne Phillips

Joanna Groom

Dale Garsed

Xavier Maldonado

Mark Shackleton

Make your next move.